Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
27.98
-0.52 (-1.82%)
Mar 28, 2024, 1:35 PM EDT - Market open

Dyne Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
123.94174.47203.14300.8514.638.12
Short-Term Investments
1.4783.87175.7544.4600
Cash & Cash Equivalents
125.42258.33378.88345.3114.638.12
Cash Growth
-51.45%-31.82%9.72%2259.99%80.11%-
Other Current Assets
3.967.263.513.770.130.03
Total Current Assets
129.38265.59382.39349.0914.768.16
Property, Plant & Equipment
33.3938.4140.961.951.490.11
Other Long-Term Assets
2.322.322.312.30.190
Total Long-Term Assets
35.7140.7343.274.251.680.11
Total Assets
165.08306.33425.66353.3316.448.27
Accounts Payable
22.945.264.033.441.260.52
Current Debt
4.724.613.89000
Other Current Liabilities
23.4418.2220.87.531.10.19
Total Current Liabilities
51.128.0928.7210.972.360.71
Long-Term Debt
22.725.8728.74000
Other Long-Term Liabilities
00000.043.38
Total Long-Term Liabilities
22.725.8728.7400.043.38
Total Liabilities
73.7953.9657.4710.972.44.09
Total Debt
27.4230.4832.64000
Debt Growth
-10.06%-6.60%----
Retained Earnings
-632.51-396.57-228.47-79.18-19.75-4.89
Comprehensive Income
0-0.57-0.27-0.0300
Shareholders' Equity
91.29252.36368.2342.3714.04-4.88
Net Cash / Debt
98227.85346.25345.3114.638.12
Net Cash / Debt Growth
-56.99%-34.19%0.27%2259.99%80.11%-
Net Cash Per Share
1.644.386.8023.995.9917.13
Working Capital
78.28237.51353.67338.1212.47.45
Book Value Per Share
1.534.867.2323.785.75-10.29
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).